Rational selection of the monoclonal α-synuclein antibody amlenetug (Lu AF82422) for the treatment of α-synucleinopathies

Pekka Kallunki, Florence Sotty, Katarina Willén, Michal Lubas, Laurent David, Malene Ambjørn, Ann-Louise Bergström, Louise Buur, Ibrahim Malik, Steffen Nyegaard, Thomas Thiilmark Eriksen, Berit O. Krogh, Jeffrey B. Stavenhagen, Kathrine J. Andersen, Lars Ø. Pedersen, Ersoy Cholak, Edward N. van den Brink, Rik Rademaker, Tom Vink, David Satijn, Paul W.H.I. Parren, Søren Christensen, Line R. Olsen, Josefine N. Søderberg, Sandra Vergo, Allan Jensen, Jan Egebjerg, Pernille Gry Wulff-Larsen, Mikkel N. Harndahl, Dina S. M. Damlund, Kaare Bjerregaard-Andersen, Karina Fog

Open source

DOI: 10.1038/s41531-024-00849-1
Published: 2025-05-22
Container: npj Parkinson's Disease
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41531-024-00849-1,
  title = {Rational selection of the monoclonal α-synuclein antibody amlenetug (Lu AF82422) for the treatment of α-synucleinopathies},
  author = {Pekka Kallunki and Florence Sotty and Katarina Willén and Michal Lubas and Laurent David and Malene Ambjørn and Ann-Louise Bergström and Louise Buur and Ibrahim Malik and Steffen Nyegaard and Thomas Thiilmark Eriksen and Berit O. Krogh and Jeffrey B. Stavenhagen and Kathrine J. Andersen and Lars Ø. Pedersen and Ersoy Cholak and Edward N. van den Brink and Rik Rademaker and Tom Vink and David Satijn and Paul W.H.I. Parren and Søren Christensen and Line R. Olsen and Josefine N. Søderberg and Sandra Vergo and Allan Jensen and Jan Egebjerg and Pernille Gry Wulff-Larsen and Mikkel N. Harndahl and Dina S. M. Damlund and Kaare Bjerregaard-Andersen and Karina Fog},
  year = {2025},
  journal = {npj Parkinson's Disease},
  doi = {10.1038/s41531-024-00849-1},
  url = {https://doi.org/10.1038/s41531-024-00849-1}
}

RIS

TY  - JOUR
TI  - Rational selection of the monoclonal α-synuclein antibody amlenetug (Lu AF82422) for the treatment of α-synucleinopathies
AU  - Pekka Kallunki
AU  - Florence Sotty
AU  - Katarina Willén
AU  - Michal Lubas
AU  - Laurent David
AU  - Malene Ambjørn
AU  - Ann-Louise Bergström
AU  - Louise Buur
AU  - Ibrahim Malik
AU  - Steffen Nyegaard
AU  - Thomas Thiilmark Eriksen
AU  - Berit O. Krogh
AU  - Jeffrey B. Stavenhagen
AU  - Kathrine J. Andersen
AU  - Lars Ø. Pedersen
AU  - Ersoy Cholak
AU  - Edward N. van den Brink
AU  - Rik Rademaker
AU  - Tom Vink
AU  - David Satijn
AU  - Paul W.H.I. Parren
AU  - Søren Christensen
AU  - Line R. Olsen
AU  - Josefine N. Søderberg
AU  - Sandra Vergo
AU  - Allan Jensen
AU  - Jan Egebjerg
AU  - Pernille Gry Wulff-Larsen
AU  - Mikkel N. Harndahl
AU  - Dina S. M. Damlund
AU  - Kaare Bjerregaard-Andersen
AU  - Karina Fog
PY  - 2025
JO  - npj Parkinson's Disease
DO  - 10.1038/s41531-024-00849-1
UR  - https://doi.org/10.1038/s41531-024-00849-1
ER  -

APA

Kallunki, P., Sotty, F., Willén, K., Lubas, M., David, L., Ambjørn, M., Bergström, A., Buur, L., Malik, I., Nyegaard, S., Eriksen, T. T., Krogh, B. O., Stavenhagen, J. B., Andersen, K. J., Pedersen, L. Ø., Cholak, E., Brink, E. N. V. D., Rademaker, R., Vink, T., Satijn, D., Parren, P. W., Christensen, S., Olsen, L. R., Søderberg, J. N., Vergo, S., Jensen, A., Egebjerg, J., Wulff-Larsen, P. G., Harndahl, M. N., Damlund, D. S. M., Bjerregaard-Andersen, K., & Fog, K. (2025). Rational selection of the monoclonal α-synuclein antibody amlenetug (Lu AF82422) for the treatment of α-synucleinopathies. npj Parkinson's Disease. https://doi.org/10.1038/s41531-024-00849-1

Source records

crossref · retrieved 2026-11-08T22:41:20.408Z